These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 8643685

  • 1. Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitors.
    Rose RE, Gong YF, Greytok JA, Bechtold CM, Terry BJ, Robinson BS, Alam M, Colonno RJ, Lin PF.
    Proc Natl Acad Sci U S A; 1996 Feb 20; 93(4):1648-53. PubMed ID: 8643685
    [Abstract] [Full Text] [Related]

  • 2. Characterization of a human immunodeficiency virus type 1 variant with reduced sensitivity to an aminodiol protease inhibitor.
    Patick AK, Rose R, Greytok J, Bechtold CM, Hermsmeier MA, Chen PT, Barrish JC, Zahler R, Colonno RJ, Lin PF.
    J Virol; 1995 Apr 20; 69(4):2148-52. PubMed ID: 7884862
    [Abstract] [Full Text] [Related]

  • 3. In vitro resistance profile of the human immunodeficiency virus type 1 protease inhibitor BMS-232632.
    Gong YF, Robinson BS, Rose RE, Deminie C, Spicer TP, Stock D, Colonno RJ, Lin PF.
    Antimicrob Agents Chemother; 2000 Sep 20; 44(9):2319-26. PubMed ID: 10952574
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Kinetic characterization of human immunodeficiency virus type-1 protease-resistant variants.
    Pazhanisamy S, Stuver CM, Cullinan AB, Margolin N, Rao BG, Livingston DJ.
    J Biol Chem; 1996 Jul 26; 271(30):17979-85. PubMed ID: 8663409
    [Abstract] [Full Text] [Related]

  • 7. Structural and kinetic analyses of the protease from an amprenavir-resistant human immunodeficiency virus type 1 mutant rendered resistant to saquinavir and resensitized to amprenavir.
    Markland W, Rao BG, Parsons JD, Black J, Zuchowski L, Tisdale M, Tung R.
    J Virol; 2000 Aug 26; 74(16):7636-41. PubMed ID: 10906218
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro selection and characterization of human immunodeficiency virus type 1 (HIV-1) isolates with reduced sensitivity to hydroxyethylamino sulfonamide inhibitors of HIV-1 aspartyl protease.
    Partaledis JA, Yamaguchi K, Tisdale M, Blair EE, Falcione C, Maschera B, Myers RE, Pazhanisamy S, Futer O, Cullinan AB.
    J Virol; 1995 Sep 26; 69(9):5228-35. PubMed ID: 7636964
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Human immunodeficiency virus type 1 protease cleavage site mutations associated with protease inhibitor cross-resistance selected by indinavir, ritonavir, and/or saquinavir.
    Côté HC, Brumme ZL, Harrigan PR.
    J Virol; 2001 Jan 26; 75(2):589-94. PubMed ID: 11134271
    [Abstract] [Full Text] [Related]

  • 13. Protease inhibitors and prevention of cross resistance.
    Levin J.
    AIDS Treat News; 1995 Oct 06; (no 232):1-3. PubMed ID: 11362875
    [Abstract] [Full Text] [Related]

  • 14. Retracing the evolutionary pathways of human immunodeficiency virus type 1 resistance to protease inhibitors: virus fitness in the absence and in the presence of drug.
    Mammano F, Trouplin V, Zennou V, Clavel F.
    J Virol; 2000 Sep 06; 74(18):8524-31. PubMed ID: 10954553
    [Abstract] [Full Text] [Related]

  • 15. Evolution of the human immunodeficiency virus type 1 protease: effects on viral replication capacity and protease robustness.
    Capel E, Martrus G, Parera M, Clotet B, Martínez MA.
    J Gen Virol; 2012 Dec 06; 93(Pt 12):2625-2634. PubMed ID: 22933665
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Characterization of human immunodeficiency virus type 1 mutants with decreased sensitivity to proteinase inhibitor Ro 31-8959.
    Jacobsen H, Yasargil K, Winslow DL, Craig JC, Kröhn A, Duncan IB, Mous J.
    Virology; 1995 Jan 10; 206(1):527-34. PubMed ID: 7831807
    [Abstract] [Full Text] [Related]

  • 18. Resistance of HIV type 1 to proteinase inhibitor Ro 31-8959.
    Eberle J, Bechowsky B, Rose D, Hauser U, von der Helm K, Gürtler L, Nitschko H.
    AIDS Res Hum Retroviruses; 1995 Jun 10; 11(6):671-6. PubMed ID: 7576926
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Analysis of resistance to human immunodeficiency virus type 1 protease inhibitors by using matched bacterial expression and proviral infection vectors.
    Maschera B, Furfine E, Blair ED.
    J Virol; 1995 Sep 10; 69(9):5431-6. PubMed ID: 7636988
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.